Year: 2021

Clene Presents Phase 2 CNM-Au8 CNS Target Engagement Data at the International Parkinson and Movement Disorder Society Virtual Congress 2021

CNM-Au8® , a catalytically active gold nanocrystal suspension, significantly improved brain energetic metabolism in Parkinson’s patientsSALT LAKE CITY, Sept. 17,...

VBL Therapeutics Announces Independent Data Safety Monitoring Committee Provides Clearance to Continue the OVAL Phase 3 Registration-Enabling Study of VB-111 in Ovarian Cancer

The OVAL Phase 3 clinical trial evaluating VB-111 in platinum-resistant ovarian cancer has recruited more than 320 patients (>80 %)...

ImageCare Centers Unveils PINK Better Mammo Service, Featuring Profound AI®, the World’s First FDA Cleared Artificial Intelligence Solution for 3D Mammography

MORRISTOWN, N.J.--(BUSINESS WIRE)--ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of ProFound AI® for Digital...

Rakovina Therapeutics Presents Preclinical Data on novel kt-3000 Series Drug Candidates at JCA-AACR Precision Medicine International Conference

VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) ("the Company"), a biopharmaceutical company committed...

ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. First international patient enrolled in BrazilTrial approximately 75% enrolledrNAPc2...

error: Content is protected !!